These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35359659)

  • 1. Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications.
    Costagliola G; Depietri G; Michev A; Riva A; Foiadelli T; Savasta S; Bonuccelli A; Peroni D; Consolini R; Marseglia GL; Orsini A; Striano P
    Front Neurol; 2022; 13():741244. PubMed ID: 35359659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay.
    Foiadelli T; Santangelo A; Costagliola G; Costa E; Scacciati M; Riva A; Volpedo G; Smaldone M; Bonuccelli A; Clemente AM; Ferretti A; Savasta S; Striano P; Orsini A
    Front Pediatr; 2023; 11():1251914. PubMed ID: 38078329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
    Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
    Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line immunotherapy in new onset refractory status epilepticus.
    Hanin A; Muscal E; Hirsch LJ
    Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
    Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
    Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol in refractory status epilepticus: A review of clinical experiences.
    Duda J; Reinert JP
    Seizure; 2022 Dec; 103():115-119. PubMed ID: 36399869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus.
    Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC
    Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).
    Maguire MJ; Jackson CF; Marson AG; Nolan SJ
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011792. PubMed ID: 27434597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES).
    Stredny CM; Case S; Sansevere AJ; Son M; Henderson L; Gorman MP
    Child Neurol Open; 2020; 7():2329048X20979253. PubMed ID: 33403221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review.
    Zhou S; Qiao J; Bai J; Wu Y; Fang H
    Ther Clin Risk Manag; 2018; 14():167-171. PubMed ID: 29416343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
    Qu XP; Vidaurre J; Peng XL; Jiang L; Zhong M; Hu Y
    Pediatr Neurol; 2020 Apr; 105():35-40. PubMed ID: 31917096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An
    Cerovic M; Di Nunzio M; Craparotta I; Vezzani A
    Front Neurol; 2023; 14():1129138. PubMed ID: 37034097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    Rheumatology (Oxford); 2020 Oct; 59(10):2711-2724. PubMed ID: 32533192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Torres AR
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate as an add-on therapy for refractory partial epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008295. PubMed ID: 28718506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol for focal refractory epilepsy.
    Brigo F; Storti M; Igwe SC
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009887. PubMed ID: 26488459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for epilepsy.
    West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.